Xencor | XNCR - Trade Debtors


Xencor reported $42.23M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
AbbVie USD 12.48B 110M Mar/2026
Alnylam Pharmaceuticals USD 912.74M 28.78M Jun/2026
Amgen USD 10.23B 1.09B Jun/2026
Arrowhead Research USD 8.56M 7.13M Jun/2026
AstraZeneca USD 18.86B 972M Jun/2026
Biogen USD 1.79B 76.6M Mar/2026
Bristol-Myers Squibb USD 13.83B 535M Jun/2026
Cytokinetics USD 6.83M 10.94M Mar/2026
GlaxoSmithKline GBP 8.07B 137M Jun/2026
J&J USD 19.05B 3.49B Jun/2026
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
MacroGenics USD 10.42M 2.95M Mar/2026
Merck USD 12.21B 435M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Pfizer USD 16.19B 19M Jun/2026
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
Xencor USD 42.23M 30.23M Jun/2026